Have you or your loved ones been diagnosed with bladder cancer?

You may be eligible to participate in a bladder cancer clinical trial.

Have you or your loved ones been diagnosed with bladder cancer? You may be eligible to participate in a bladder cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Bladder Cancer Clinical Trial in London Ontario
NCT01869413 | Phase 2 phase 3 | Interventional

Have you or your loved ones been diagnosed with bladder cancer?

You may be eligible to participate in a bladder cancer clinical trial.

Have you or your loved ones been diagnosed with bladder cancer? You may be eligible to participate in a bladder cancer clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 354 Participants

A cystectomy is the removal of the bladder and adjacent organs in patients with bladder cancer. This often results in significant blood loss, and about 60% of patients will require a blood transfusion during or up to 30 days after surgery. Significant blood loss may result in cardiovascular morbidity, and the use of blood products are expensive and expose patients to risk. Tranexamic acid reduces breakdown of hemostatic blood clots and it has therapeutic benefit when used in other surgical procedures to reduce blood loss and the need for transfusion. The current study will be the first to evaluate whether tranexamic acid is effective and safe to use during radical cystectomy. The results of the study will have an immediate impact on patient care.